Report Detail

Machinery & Equipment Global Diaphragm Valves for Pharmaceutical Process Market Report, History and Forecast 2017-2028

  • RnM4393620
  • |
  • 09 March, 2022
  • |
  • Global
  • |
  • 175 Pages
  • |
  • QYResearch
  • |
  • Machinery & Equipment

Summary:

Market Analysis and Insights: Global Diaphragm Valves for Pharmaceutical Process Market
Due to the COVID-19 pandemic, the global Diaphragm Valves for Pharmaceutical Process market size was value at US$ 96.48 million in 2021 and is forecast to be a readjusted size of US$ 152.71 million by 2028 with a CAGR of 6.91% during the forecast period 2022-2028.
The global main manufacturers of Diaphragm Valves for Pharmaceutical Process include GEMU, Crane Co. (Saunders), SAMSON (SED Flow Control Gmbh), Burkert Fluid Control Systems, INOXPA SAU, etc. In 2021, the global five largest players have a share approximately 64.02% in terms of revenue.
The North America Diaphragm Valves for Pharmaceutical Process market size was US$ 26.30 million in 2021, while China was about US$ 9.55 million. As for the Europe Diaphragm Valves for Pharmaceutical Process landscape, Germany is projected to reach US$ 47.24 million by 2028. And in Asia, the notable markets are Japan and South Korea, CAGR is 6.86% and 6.67% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, Stainless Steel accounting for 62.03% of the Diaphragm Valves for Pharmaceutical Process global market in 2021, is projected to value US$ 104.26 million by 2028, growing at a revised 8.11% CAGR from 2022 to 2028. While Pharmaceutical Water System segment is altered to an 8.46% CAGR throughout this forecast period and will hold a share about 40.36% in 2028.
Global Diaphragm Valves for Pharmaceutical Process Scope and Market Size
The global Diaphragm Valves for Pharmaceutical Process market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Diaphragm Valves for Pharmaceutical Process market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company
GEMU
Crane Co. (Saunders)
SAMSON (SED Flow Control Gmbh)
Burkert Fluid Control Systems
INOXPA SAU
Aquasyn
Alfa Laval
ITT Engineered Valves
NDV
Hylok
Swagelok
Parker Hannifin
Watson-Marlow Fluid Technology Group (ASEPCO)
Steel & O'Brien
Shanghai REMY
Rodaff Fluid Tech

Segment by Type
Stainless Steel
Plastic
Others

Segment by Application
Pharmaceutical Water System
CIP and SIP System
Filtration and Filling
Other

By Region
North America
USA
Canada
Mexico

Asia-Pacific
China
Japan
India
China Taiwan
Southeast Asia
Korea

Europe
Germany
France
UK
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa


Table of Contents

    1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET OVERVIEW 1

    • 1.1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCT OVERVIEW 1
    • 1.2 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SEGMENT BY TYPE 4
      • 1.2.1 STAINLESS STEEL 4
      • 1.2.2 PLASTIC 6
      • 1.2.3 OTHERS 7
    • 1.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SIZE BY TYPE 9
      • 1.3.1 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SIZE OVERVIEW BY TYPE (2017-2028) 10
      • 1.3.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022) 12
      • 1.3.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY TYPE (2023-2028) 13
    • 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE 14
      • 1.4.1 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY TYPE (2017-2022) 14
      • 1.4.2 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY TYPE (2017-2022) 15
      • 1.4.3 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY TYPE (2017-2022) 16
      • 1.4.4 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY TYPE (2017-2022) 17
      • 1.4.5 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY TYPE (2017-2022) 18

    2 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET COMPETITION BY COMPANY 20

    • 2.1 GLOBAL TOP PLAYERS BY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES (2017-2022) 20
    • 2.2 GLOBAL TOP PLAYERS BY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS REVENUE (2017-2022) 21
    • 2.3 GLOBAL TOP PLAYERS BY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRICE (2017-2022) 23
    • 2.4 GLOBAL TOP MANUFACTURERS DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MANUFACTURING BASE DISTRIBUTION, SALES AREA 24
    • 2.5 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET COMPETITIVE SITUATION AND TRENDS 24
      • 2.5.1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET CONCENTRATION RATE (2017-2022) 24
      • 2.5.2 GLOBAL 5 AND 10 LARGEST MANUFACTURERS BY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES AND REVENUE IN 2021 25
    • 2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS AS OF 2021) 27
    • 2.7 ESTABLISH DATE OF KEY MANUFACTURERS 29
    • 2.8 KEY MANUFACTURERS DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCT OFFERED 30
    • 2.9 MERGERS & ACQUISITIONS, EXPANSION 31

    3 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS STATUS AND OUTLOOK BY REGION 32

    • 3.1 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028 32
    • 3.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY REGION 32
      • 3.2.1 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY REGION (2017-2022) 32
      • 3.2.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY REGION (2017-2022) 33
      • 3.2.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022) 34
    • 3.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY REGION 34
      • 3.3.1 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY REGION (2023-2028) 34
      • 3.3.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY REGION (2023-2028) 35
      • 3.3.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028) 35

    4 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY APPLICATION 36

    • 4.1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SEGMENT BY APPLICATION 36
      • 4.1.1 PHARMACEUTICAL WATER SYSTEM 36
      • 4.1.2 CIP AND SIP SYSTEM 37
      • 4.1.3 FILTRATION AND FILLING 39
      • 4.1.4 OTHER 40
    • 4.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SIZE BY APPLICATION 42
      • 4.2.1 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET SIZE OVERVIEW BY APPLICATION (2017-2028) 43
      • 4.2.2 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022) 44
      • 4.2.3 GLOBAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 46
    • 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION 48
      • 4.3.1 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY APPLICATION (2017-2022) 48
      • 4.3.2 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY APPLICATION (2017-2022) 49
      • 4.3.3 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY APPLICATION (2017-2022) 49
      • 4.3.4 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY APPLICATION (2017-2022) 50
      • 4.3.5 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES BREAKDOWN BY APPLICATION (2017-2022) 51

    5 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY COUNTRY 53

    • 5.1 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY COUNTRY 53
      • 5.1.1 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2017-2022) 53
      • 5.1.2 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2017-2022) 53
    • 5.2 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY COUNTRY 54
      • 5.2.1 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2023-2028) 54
      • 5.2.2 NORTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2023-2028) 55

    6 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY COUNTRY 56

    • 6.1 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY COUNTRY 56
      • 6.1.1 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2017-2022) 56
      • 6.1.2 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2017-2022) 56
    • 6.2 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY COUNTRY 57
      • 6.2.1 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2023-2028) 57
      • 6.2.2 EUROPE DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2023-2028) 58

    7 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY REGION 60

    • 7.1 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY REGION 60
      • 7.1.1 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY REGION (2017-2022) 60
      • 7.1.2 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY REGION (2017-2022) 61
    • 7.2 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY REGION 61
      • 7.2.1 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY REGION (2023-2028) 61
      • 7.2.2 ASIA-PACIFIC DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY REGION (2023-2028) 62

    8 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY COUNTRY 64

    • 8.1 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY COUNTRY 64
      • 8.1.1 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2017-2022) 64
      • 8.1.2 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2017-2022) 64
    • 8.2 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY COUNTRY 65
      • 8.2.1 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2023-2028) 65
      • 8.2.2 SOUTH AMERICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2023-2028) 65

    9 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BY COUNTRY 67

    • 9.1 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS HISTORIC MARKET SIZE BY COUNTRY 67
      • 9.1.1 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2017-2022) 67
      • 9.1.2 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2017-2022) 67
    • 9.2 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS FORECASTED MARKET SIZE BY COUNTRY 68
      • 9.2.1 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VOLUME BY COUNTRY (2023-2028) 68
      • 9.2.2 MIDDLE EAST AND AFRICA DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES IN VALUE BY COUNTRY (2023-2028) 68

    10 COMPANY PROFILES AND KEY FIGURES IN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS BUSINESS 70

    • 10.1 GEMU 70
      • 10.1.1 GEMU CORPORATION INFORMATION 70
      • 10.1.2 GEMU INTRODUCTION AND BUSINESS OVERVIEW 70
      • 10.1.3 GEMU DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 72
      • 10.1.4 GEMU DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 72
      • 10.1.5 GEMU RECENT DEVELOPMENT 75
    • 10.2 CRANE CO.(SAUNDERS) 76
      • 10.2.1 CRANE CO.(SAUNDERS) CORPORATION INFORMATION 76
      • 10.2.2 CRANE CO.(SAUNDERS) INTRODUCTION AND BUSINESS OVERVIEW 77
      • 10.2.3 CRANE CO.(SAUNDERS) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 78
      • 10.2.4 CRANE CO.(SAUNDERS) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 78
      • 10.2.5 CRANE CO.(SAUNDERS) RECENT DEVELOPMENT 80
    • 10.3 SAMSON (SED FLOW CONTROL GMBH) 80
      • 10.3.1 SAMSON (SED FLOW CONTROL GMBH) CORPORATION INFORMATION 80
      • 10.3.2 SAMSON (SED FLOW CONTROL GMBH) INTRODUCTION AND BUSINESS OVERVIEW 81
      • 10.3.3 SAMSON (SED FLOW CONTROL GMBH) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 82
      • 10.3.4 SAMSON (SED FLOW CONTROL GMBH) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 82
      • 10.3.5 SAMSON (SED FLOW CONTROL GMBH) RECENT DEVELOPMENT 85
    • 10.4 BURKERT FLUID CONTROL SYSTEMS 85
      • 10.4.1 BURKERT FLUID CONTROL SYSTEMS CORPORATION INFORMATION 85
      • 10.4.2 BURKERT FLUID CONTROL SYSTEMS INTRODUCTION AND BUSINESS OVERVIEW 86
      • 10.4.3 BURKERT FLUID CONTROL SYSTEMS DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 86
      • 10.4.4 BURKERT FLUID CONTROL SYSTEMS DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 87
    • 10.5 INOXPA SAU 90
      • 10.5.1 INOXPA SAU CORPORATION INFORMATION 90
      • 10.5.2 INOXPA SAU INTRODUCTION AND BUSINESS OVERVIEW 91
      • 10.5.3 INOXPA SAU DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 91
      • 10.5.4 INOXPA SAU DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 91
    • 10.6 AQUASYN 94
      • 10.6.1 AQUASYN CORPORATION INFORMATION 94
      • 10.6.2 AQUASYN INTRODUCTION AND BUSINESS OVERVIEW 94
      • 10.6.3 AQUASYN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 95
      • 10.6.4 AQUASYN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 95
    • 10.7 ALFA LAVAL 97
      • 10.7.1 ALFA LAVAL CORPORATION INFORMATION 97
      • 10.7.2 ALFA LAVAL INTRODUCTION AND BUSINESS OVERVIEW 97
      • 10.7.3 ALFA LAVAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 98
      • 10.7.4 ALFA LAVAL DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 98
    • 10.8 ITT 100
      • 10.8.1 ITT CORPORATION INFORMATION 100
      • 10.8.2 ITT INTRODUCTION AND BUSINESS OVERVIEW 100
      • 10.8.3 ITT DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 101
      • 10.8.4 ITT DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 101
    • 10.9 NDV 103
      • 10.9.1 NDV CORPORATION INFORMATION 103
      • 10.9.2 NDV INTRODUCTION AND BUSINESS OVERVIEW 104
      • 10.9.3 NDV DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 104
      • 10.9.4 NDV DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 105
    • 10.10 HYLOK 106
      • 10.10.1 HYLOK CORPORATION INFORMATION 106
      • 10.10.2 HYLOK INTRODUCTION AND BUSINESS OVERVIEW 106
      • 10.10.3 HYLOK DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 107
      • 10.10.4 HYLOK DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 107
    • 10.11 SWAGELOK 110
      • 10.11.1 SWAGELOK CORPORATION INFORMATION 110
      • 10.11.2 SWAGELOK INTRODUCTION AND BUSINESS OVERVIEW 111
      • 10.11.3 SWAGELOK DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 111
      • 10.11.4 SWAGELOK DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 112
      • 10.11.5 SWAGELOK RECENT DEVELOPMENT 114
    • 10.12 PARKER HANNIFIN 114
      • 10.12.1 PARKER HANNIFIN CORPORATION INFORMATION 114
      • 10.12.2 PARKER HANNIFIN INTRODUCTION AND BUSINESS OVERVIEW 115
      • 10.12.3 PARKER HANNIFIN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 115
      • 10.12.4 PARKER HANNIFIN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 116
    • 10.13 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) 120
      • 10.13.1 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) CORPORATION INFORMATION 120
      • 10.13.2 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) INTRODUCTION AND BUSINESS OVERVIEW 121
      • 10.13.3 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 123
      • 10.13.4 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 123
      • 10.13.5 WATSON-MARLOW FLUID TECHNOLOGY GROUP (ASEPCO) RECENT DEVELOPMENT 126
    • 10.14 STEEL & O'BRIEN 127
      • 10.14.1 STEEL & O'BRIEN CORPORATION INFORMATION 127
      • 10.14.2 STEEL & O'BRIEN INTRODUCTION AND BUSINESS OVERVIEW 127
      • 10.14.3 STEEL & O'BRIEN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 128
      • 10.14.4 STEEL & O'BRIEN DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 128
    • 10.15 SHANGHAI REMY 132
      • 10.15.1 SHANGHAI REMY CORPORATION INFORMATION 132
      • 10.15.2 SHANGHAI REMY INTRODUCTION AND BUSINESS OVERVIEW 132
      • 10.15.3 SHANGHAI REMY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 133
      • 10.15.4 SHANGHAI REMY DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 133
    • 10.16 RODAFF FLUID TECH 134
      • 10.16.1 RODAFF FLUID TECH CORPORATION INFORMATION 134
      • 10.16.2 RODAFF FLUID TECH INTRODUCTION AND BUSINESS OVERVIEW 135
      • 10.16.3 RODAFF FLUID TECH DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS SALES, REVENUE AND GROSS MARGIN (2017-2022) 135
      • 10.16.4 RODAFF FLUID TECH DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS PRODUCTS OFFERED 135

    11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 137

    • 11.1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS KEY RAW MATERIALS 137
      • 11.1.1 KEY RAW MATERIALS 137
      • 11.1.2 KEY RAW MATERIALS PRICE 137
      • 11.1.3 RAW MATERIALS KEY SUPPLIERS 137
    • 11.2 MANUFACTURING COST STRUCTURE 138
      • 11.2.1 RAW MATERIALS 138
      • 11.2.2 LABOR COST 138
      • 11.2.3 MANUFACTURING EXPENSES 138
    • 11.3 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS INDUSTRIAL CHAIN ANALYSIS 139
    • 11.4 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET DYNAMICS 139
      • 11.4.1 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS INDUSTRY TRENDS 139
      • 11.4.2 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET DRIVERS 140
      • 11.4.3 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET CHALLENGES 141
      • 11.4.4 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS MARKET RESTRAINTS 141

    12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 142

    • 12.1 SALES CHANNEL 142
    • 12.2 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS DISTRIBUTORS 142
    • 12.3 DIAPHRAGM VALVES FOR PHARMACEUTICAL PROCESS DOWNSTREAM CUSTOMERS 144

    13 RESEARCH FINDINGS AND CONCLUSION 145

      14 APPENDIX 147

      • 14.1 RESEARCH METHODOLOGY 147
        • 14.1.1 METHODOLOGY/RESEARCH APPROACH 147
        • 14.1.2 DATA SOURCE 150
      • 14.2 AUTHOR DETAILS 153

      Summary:
      Get latest Market Research Reports on Diaphragm Valves for Pharmaceutical Process. Industry analysis & Market Report on Diaphragm Valves for Pharmaceutical Process is a syndicated market report, published as Global Diaphragm Valves for Pharmaceutical Process Market Report, History and Forecast 2017-2028. It is complete Research Study and Industry Analysis of Diaphragm Valves for Pharmaceutical Process market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,350.00
      $6,700.00
      2,639.80
      5,279.60
      3,082.00
      6,164.00
      521,260.00
      1,042,520.00
      279,323.00
      558,646.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report